Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desflurane end-tidal concentration with remifentanil target-controlled infusion during musculoskeletal surgery
ACTRN12610000930088Phase 4Completed
- Sponsor
- Samsung Changwon Medical Center
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of desflurane and remifentanil, sponsored by Samsung Changwon Medical Center. Started Mar 2009; status: completed.
02
Drugs
desfluraneremifentanil
Beyond the preview
Go deeper on ACTRN12610000930088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000930088.